Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
19.26
-0.45 (-2.28%)
At close: Nov 7, 2025, 4:00 PM EST
19.29
+0.03 (0.16%)
After-hours: Nov 7, 2025, 7:58 PM EST
Apellis Pharmaceuticals Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$32.83
Upside
+70.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $40 → $36 | Buy | Maintains | $40 → $36 | +86.92% | Nov 5, 2025 |
| Mizuho | Mizuho | Hold Maintains $24 → $19 | Hold | Maintains | $24 → $19 | -1.35% | Nov 3, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $52 → $45 | Strong Buy | Maintains | $52 → $45 | +133.64% | Oct 31, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +133.64% | Oct 31, 2025 |
| Baird | Baird | Buy Maintains $50 → $52 | Buy | Maintains | $50 → $52 | +169.99% | Oct 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $45 | Strong Buy | Maintains | $57 → $45 | +133.64% | Oct 31, 2025 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $29 → $32 | Hold → Buy | Upgrades | $29 → $32 | +66.15% | Oct 15, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $26 → $18 | Hold → Strong Sell | Downgrades | $26 → $18 | -6.54% | Sep 26, 2025 |
| Mizuho | Mizuho | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | +14.23% | Aug 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $35 → $37 | Buy | Maintains | $35 → $37 | +92.11% | Aug 4, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $46 → $52 | Strong Buy | Maintains | $46 → $52 | +169.99% | Aug 1, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | -1.35% | Aug 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $39 → $40 | Buy | Maintains | $39 → $40 | +107.68% | Aug 1, 2025 |
| Raymond James | Raymond James | Buy Maintains $52 → $50 | Buy | Maintains | $52 → $50 | +159.61% | Aug 1, 2025 |
| Mizuho | Mizuho | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | +9.03% | Jul 29, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.